Non-Invasive Vagus Nerve Stimulation Wearable Marks a Shift Toward At-Home Recovery Support Across the U.S.

At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...

TMS Therapy for Depression: How It Works & Benefits

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

Brain Implant Can Read Movement Of Parkinson's Patients, Opening Door To More Effective Treatment

An experimental brain implant can capture the signals of movement-related brain regions while Parkinson’s patients perform daily activities like walking to the kitchen or strolling through a park, ...
Kalkine Media

LivaNova (NASDAQ:LIVN) Procedure Trends Intersect With Nasdaq Today Moves

LivaNova PLC (NASDAQ:LIVN) has moved into sharper market focus as trading flows reflect heightened positioning adjustments ...
Medscape

New Nanotech Brain Implants Self-Implant Without Surgery

MIT researchers have created subcellular ‘circulatronic’ brain implants that can be administered via injection and self-implant to target a variety of ailments directly.

Neuspera Medical Announces Milestone Case of Traditional Sacral Neuromodulation (SNM) System Removed and Replaced With the Company's Integrated SNM System for Urinary Urge ...

Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced a milestone patient revision from a traditional sacral neuromodulation ...

WAT Medical's EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial

WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world's most reputable and high-impact surgical journals. The study confirms that ...
Frontiers

Long-term efficacy of neuromodulation in chronic pain management: a single-center retrospective study

Department of Neurosurgery, University Hospital and Faculty of Medicine and Dentistry, Olomouc, Czechia Objectives: Neuromodulation is an advanced therapy for managing chronic pain by modulating nerve ...
Morningstar

Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants

CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...
BioWorld

Neuromodulation for MDD heads home

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S. FDA enabling at-home use of neuromodulation devices may provide a bright ...
Monthly Prescribing Reference

FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder

The Food and Drug Administration (FDA) has cleared Proliv™Rx, an at-home neuromodulation therapy, for use as adjunctive treatment for adults with major depressive disorder (MDD) who have failed to ...